C41H46BrN7O7 — CID 170978713
4-[(3R,5R)-5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[9-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxynon-5-ynyl]-N-methylbenzamide (PubChem CID 170978713) has the molecular formula C41H46BrN7O7 and a molecular weight of 828.76 g/mol. Its IUPAC name is 4-[(3R,5R)-5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[9-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxynon-5-ynyl]-N-methylbenzamide.
| Compound Name | 4-[(3R,5R)-5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[9-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxynon-5-ynyl]-N-methylbenzamide |
|---|---|
| PubChem CID | 170978713 |
| Molecular Formula | C41H46BrN7O7 |
| Molecular Weight | 828.76 g/mol |
| Exact Mass | 827.26 |
| IUPAC Name | 4-[(3R,5R)-5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[9-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxynon-5-ynyl]-N-methylbenzamide |
| SMILES | CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccc(C(=O)N(C)CCCCC#CCCCOc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc2)C1 |
| InChI | InChI=1S/C41H46BrN7O7/c1-46-24-28(22-29(25-46)44-31-23-43-48(3)41(55)36(31)42)26-14-16-27(17-15-26)38(52)47(2)20-9-7-5-4-6-8-10-21-56-33-13-11-12-30-35(33)40(54)49(39(30)53)32-18-19-34(50)45-37(32)51/h11-17,23,28-29,32,44H,5,7-10,18-22,24-25H2,1-3H3,(H,45,50,51)/t28-,29+,32?/m0/s1 |
| InChIKey | RXAAKJIXWDKDSX-QSVHXPHUSA-N |
| XLogP | 3.95 |
| TPSA | 163.25 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 56 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 828.76 |
| LogP ≤ 5 | 3.95 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|